Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000378:metabolism; D000818:Animals; D001249:Asthma / Q000276:immunology* / Q000378:metabolism; D018122:B7-1 Antigen / Q000096:biosynthesis; D002478:Cells, Cultured; D003545:Cysteine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000276:immunology / Q000378:metabolism; D016207:Cytokines / Q000096:biosynthesis; D007113:Immunity, Innate / Q000276:immunology; D016130:Immunophenotyping; D060945:Inducible T-Cell Co-Stimulator Ligand; D008024:Ligands; D008074:Lipoproteins / Q000008:administration & dosage / Q000276:immunology / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism* / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage / Q000276:immunology; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D011956:Receptors, Cell Surface / Q000378:metabolism* / Q000502:physiology; D018418:Th2 Cells / Q000276:immunology* / Q000378:metabolism*; D051195:Toll-Like Receptor 2; D051193:Toll-Like Receptors
D000276:Adjuvants, Immunologic; D018122:B7-1 Antigen; C408982:CPG-oligonucleotide; D016207:Cytokines; D060945:Inducible T-Cell Co-Stimulator Ligand; D008024:Ligands; D008074:Lipoproteins; D008562:Membrane Glycoproteins; D009838:Oligodeoxyribonucleotides; D011956:Receptors, Cell Surface; D051195:Toll-Like Receptor 2; D051193:Toll-Like Receptors; C069172:2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine; D010047:Ovalbumin; D003545:Cysteine